DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.
Publication
, Conference
Yu, EY; Pieczonka, CM; Briganti, A; Murphy, DG; Lebret, T; Luz, M; Suzuki, H; Thiery-Vuillemin, A; Ortiz, JA; Guan, R; Armstrong, AJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Yu, E. Y., Pieczonka, C. M., Briganti, A., Murphy, D. G., Lebret, T., Luz, M., … Armstrong, A. J. (2020). DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Yu, Evan Y., Christopher Michael Pieczonka, Alberto Briganti, Declan G. Murphy, Thierry Lebret, Murilo Luz, Hiroyoshi Suzuki, et al. “DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Yu EY, Pieczonka CM, Briganti A, Murphy DG, Lebret T, Luz M, et al. DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Yu, Evan Y., et al. “DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Yu EY, Pieczonka CM, Briganti A, Murphy DG, Lebret T, Luz M, Suzuki H, Thiery-Vuillemin A, Ortiz JA, Guan R, Armstrong AJ. DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis